Inventiva S a (IVA)
Sector • Healthcare Industry • Major Pharmaceutical Preparations |
Industry • Major Pharmaceutical Preparations |
Sector • Healthcare |
The Major Pharmaceutical Preparations company released Revenue of $13.64048 millions, in the fourth quarter of 2022
Inventiva S A delivered fourth quarter of 2022 operating shortfall of $-63.9632 millions
Published Apr 02 2023
CSIMarket Team / CSIMarket.com
IVA proclaimed $13.64048 millions, in Revenue in the fourth quarter of 2022.
For the fourth quarter of 2022 Inventiva S A realized net loss of $-60.787 million, higher than $-55.591 million a year ago.
Inventiva S A is expected to report next financial recent numbers on March 29, 2024.
For the fourth quarter of 2022 Inventiva S A realized net loss of $-60.787 million, higher than $-55.591 million a year ago.
Inventiva S A is expected to report next financial recent numbers on March 29, 2024.